Real-time enrollment status for this venous thromboembolism (vte) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:06 PM UTC
| NCT Number | NCT07493304 |
| Recruiting Status | Recruiting |
| Condition | Venous Thromboembolism (VTE) |
| Phase | PHASE3 |
| Target Enrollment | 1,600 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of July 18, 2026: Clinical trial NCT07493304 is currently recruiting participants. This phase3 study for venous thromboembolism (vte) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07493304 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07493304 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.